|
|
||||||||
The Annals of Thoracic Surgery, Vol 56, 1085-1089, Copyright © 1993 by The Society of Thoracic Surgeons
A Mugge, MR Barton, J Cremer, R Frombach and PR Lichtlen
Vascular responses to endogenous agonists may determine patency rates of
bypass graft conduits. The effect of constrictors (noradrenaline,
phenylephrine, serotonin, histamine, angiotensin II) and dilators
(acetylcholine, substance P, bradykinin, nitroglycerin) were compared in
human internal mammary and inferior epigastric arteries in vitro. The
latter vessel type has been recently advocated as an additional conduit for
coronary artery bypass grafting. Whereas the alpha- adrenoceptor-
(noradrenaline, phenylephrine) and serotonin receptor- mediated
contractions were similar in both vessels, histamine-induced contractions
were greatly enhanced in internal mammary arteries (maximal responses in
percent of 80 mmol/L KCl, 131% +/- 15% versus 59% +/- 8%). Maximal
contractions in response to angiotensin II were greater in inferior
epigastric arteries (50% +/- 6% versus 25% +/- 5%). The
endothelium-independent relaxations in response to nitroglycerin were
identical in both vessels. In contrast, the endothelium-dependent
relaxations in response to acetylcholine, substance P, and bradykinin were
significantly greater in the inferior epigastric than in the internal
mammary arteries (maximal relaxations expressed as percent of prostaglandin
F2 alpha-induced precontraction: acetylcholine, 94% +/- 5% versus 77% +/-
5%; substance P, 85% +/- 4% versus 24% +/- 5%; bradykinin, 77% +/- 5%
versus 26% +/- 3%). It is concluded that the inferior epigastric artery has
a high endothelial capacity to release endothelium-derived relaxing factor.
It appears that the inferior epigastric artery possesses credentials to be
successfully used for coronary artery bypass grafting.
ARTICLES
Different vascular reactivity of human internal mammary and inferior epigastric arteries in vitro
Division of Cardiology, Hannover Medical School, Germany.
This article has been cited by other articles:
![]() |
M. Barton and B. Glodny Endothelin receptor blockade and nitric oxide bioactivity: [Cardiovascular Research 2001;49:146-151] Cardiovasc Res, October 1, 2001; 52(1): 161 - 163. [Full Text] [PDF] |
||||
![]() |
O Gurne, P Chenu, M Buche, Y Louagie, P Eucher, B Marchandise, E Rombaut, D Blommaert, and E Schroeder Adaptive mechanisms of arterial and venous coronary bypass grafts to an increase in flow demand Heart, September 1, 1999; 82(3): 336 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Rosenfeldt, G.-W. He, B. F. Buxton, and J. A. Angus Pharmacology of coronary artery bypass grafts Ann. Thorac. Surg., March 1, 1999; 67(3): 878 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-W. He Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice Ann. Thorac. Surg., January 1, 1999; 67(1): 277 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Chester, A. J. Marchbank, J. A.A. Borland, M. H. Yacoub, and D. P. Taggart Comparison of the morphologic and vascular reactivity of the proximal and distal radial artery Ann. Thorac. Surg., December 1, 1998; 66(6): 1972 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-W. He, C.-Q. Yang, and A. Starr Overview of the Nature of Vasoconstriction in Arterial Grafts for Coronary Operations Ann. Thorac. Surg., March 1, 1995; 59(3): 676 - 683. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |